Guibourt; Nathalie
Patent Applications and Registrations
Patent applications and USPTO patent grants for Guibourt; Nathalie.The latest application filed is for "phenylcyclopropylamine derivatives and their medical use".
- Guibourt; Nathalie - Bercelona N/A ES
- GUIBOURT; Nathalie - Barcelona ES
- Guibourt; Nathalie - Sevilla ES
| Patent | Date |
|---|---|
| Potent selective LSD1 inhibitors and dual LSD1/MAO-B inhibitors for antiviral use Grant 9,616,058 - Cesar Castro Palomino Laria , et al. April 11, 2 | 2017-04-11 |
| Phenylcyclopropylamine Derivatives And Their Medical Use App 20160045456 - GUIBOURT; Nathalie ; et al. | 2016-02-18 |
| Phenylcyclopropylamine derivatives and their medical use Grant 8,993,808 - Guibourt , et al. March 31, 2 | 2015-03-31 |
| Inhibitors For Antiviral Use App 20130274267 - Cesar Castro Palomino Laria; Julio ; et al. | 2013-10-17 |
| Oxidase inhibitors and their use Grant 8,524,717 - Guibourt , et al. September 3, 2 | 2013-09-03 |
| Phenylcyclopropylamine Derivatives And Their Medical Use App 20120004262 - Guibourt; Nathalie ; et al. | 2012-01-05 |
| Oxidase inhibitors and their use App 20110263604 - Guibourt; Nathalie ; et al. | 2011-10-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 